Effects of systane® balance on noninvasive tear film Break-Up time in patients with Lipid-Deficient dry eye

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 2365-2372

  Aguilar, Alejandro J ^a   Marquez, Maria I ^a   Albera, Paula A ^a   Tredicce, Jorge L ^a   Berra, Alejandro ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Artificial tears; Conjunctival staining; Corneal staining; Goblet cells

Indexed keywords

ARTIFICIAL TEAR; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CAUCASIAN; CELL COUNT; CELL DENSITY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; CYTOLOGY; DRUG EFFICACY; DRUG RESPONSE; DRY EYE; FEMALE; GOBLET CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEIBOMIAN GLAND DYSFUNCTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TEAR FILM; TREATMENT DURATION; VISUAL ACUITY;

EID: 84912064211     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S70623     Document Type: Article

References (16)

1. Shimazaki-Den S, Dogru M, Higa K, Shimazaki J. Symptoms, visual function, and mucin expression of eyes with tear film instability. Cornea. 2013;32(9):1211-1218.
2. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405-412.
3. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762-770.
4. McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Surv Ophthalmol. 2012;57(4):293-316.
5. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472-478.
6. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930-1937.
7. Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52(4):1922-1929.
8. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90-100.
9. Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011;5:783-790.
10. Peters K, Millar T. The role of different phospholipids on tear break-up time using a model eye. Curr Eye Res. 2002;25(1):55-60.
11. Sindt CW, Foulks GN. Efficacy of an artificial tear emulsion in patients with dry eye associated with meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1713-1722.
12. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
13. Nelson JD, Havener VR, Cameron JD. Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol. 1983;101(12):1869-1872.
14. O’Brien PD, Collum LM. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 2004;4(4):314-319.
15. Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004;28(1):55-62.
16. Unlü C, Güney E, Akçay Bİ, Akçalı G, Erdoğan G, Bayramlar H. Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology. Clin Ophthalmol. 2012;6:1303-1306.